Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled Study to Investigate the Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome
Conditions
Interventions
BRC-002
BRC-002 Placebo
Locations
2
United States
Altman Clinical and Translational Research Institute
La Jolla, California, United States
University of California, San Diego
San Diego, California, United States
Start Date
June 1, 2024
Primary Completion Date
June 1, 2029
Completion Date
June 1, 2029
Last Updated
June 7, 2024
NCT07473635
NCT05777889
NCT05052736
NCT04144972
NCT06453447
NCT05986461
Lead Sponsor
University of California, San Diego
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions